Anthera Pharmaceuticals (ANTH)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Oct 4, 2024 10:16 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Anthera Pharmaceuticals, Inc. [ANTH]
Reports for Purchase
Showing records 1 - 20 ( 42 total )
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
ValuEngine Detailed Valuation Report for ANTH
Provider: ValuEngine, Inc
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage
Provider: H.C. Wainwright & Co., Inc.
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Continue to Believe Risk/Reward Is Attractive Heading Into March Sollpura Data
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Where to From Here? Our Thoughts on ANTH''s 2017 Path Ahead; Adjusting PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
We are initiating with a Buy rating and $10 price target.
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
We are dropping coverage due to realignment of research coverage since analyst departure
Provider: WEDBUSH SECURITIES INC.
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of March 18
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of March 4
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q4:2011 Financials Uneventful; Awaiting Interim Analyses in March; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NASH D
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of February 19
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of February 12
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of January 22
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of January 8
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Anthera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of December
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L